Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($) $ in Thousands	Total	Series A Redeemable Convertible Preferred Stock	Series B Redeemable Convertible Preferred Stock	Series C Redeemable Convertible Preferred Stock	Series D Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning Balance at Dec. 31, 2020	$ (95,718)					$ 8	$ 7,109	$ (102,835)
Beginning Balance, Shares at Dec. 31, 2020		11,596,280	5,166,203	7,588,254	6,902,872
Beginning Balance at Dec. 31, 2020		$ 53,593	$ 36,336	$ 53,221	$ 89,904
Beginning Balance at Dec. 31, 2020						8,391,793
Temporary Equity, Conversion of redeemable convertible preferred stock into common stock upon initial public offering, shares		(11,596,280)	(5,166,203)	(7,588,254)	(6,902,872)
Conversion of redeemable convertible preferred stock into common stock initial public offering		$ (53,593)	$ (36,336)	$ (53,221)	$ (89,904)
Conversion of redeemable convertible preferred stock into common stock upon initial public offering, shares						31,253,609
Conversion of redeemable convertible preferred stock into common stock upon initial public offering	233,053					$ 31	233,022
Initial public offering, net of underwriting discounts, commissions and net of offering costs of $11,786						7,500,000
Initial public offering, net of underwriting discounts, commissions and net of offering costs of $11,786	115,714					$ 8	115,706
Underwriters' exercise of overallotment option, net of underwriting discounts, commissions and initial public offering costs of $276	3,003						3,003
Underwriters' exercise of overallotment option, net of underwriting discounts, commissions and initial public offering costs of $276, Shares						192,877
Shares repurchased for cashless exercise	(10)						(10)
Shares repurchased for cashless exercise, Shares						(1,221)
Exercise of common stock options	$ 181						181
Exercise of common stock options						155,821
Exercise of common stock warrants	19,303
Stock-based compensation	$ 4,161						4,161
Net loss	$ (58,160)							(58,160)
Ending Balance , Shares at Dec. 31, 2021	0
Ending Balance, Shares at Dec. 31, 2021						47,512,182
Ending Balance at Dec. 31, 2021	$ 202,224					$ 47	363,172	(160,995)
Vesting of restricted stock, Shares						252,431
Exercise of common stock options	141					$ 1	140
Exercise of common stock options						188,338
Issuance of common stock under employee stock purchase plan, Shares						100,645
Issuance of common stock under employee stock purchase plan	148						148
Stock-based compensation	7,844						7,844
Net loss	$ (114,646)							(114,646)
Ending Balance , Shares at Dec. 31, 2022	0
Ending Balance, Shares at Dec. 31, 2022						48,053,596
Ending Balance at Dec. 31, 2022	$ 95,711					$ 48	$ 371,304	$ (275,641)